Dimension Therapeutics adds director
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Dimension Therapeutics Inc. appointed John Hohneker, an executive vice president and head of research and development at FORMA Therapeutics Inc., to its board of directors, effective Jan. 18.
Hohneker will serve as a class 1 director until Dimension's next annual stockholders' meeting following Dec. 31, 2018.
